Cargando…

Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018

OBJECTIVE: Blood pressure (BP) control rates among adult patients taking antihypertensive medications in the United States have not improved over the last decade. Many CKD adults require more than one class of antihypertensive agent to reach the BP target recommended by the guidelines. However, no s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fanghua, Sun, Anbang, Wu, Feng, Zhang, Dongshan, Zhao, Zhanzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947777/
https://www.ncbi.nlm.nih.gov/pubmed/36844731
http://dx.doi.org/10.3389/fcvm.2023.990997
_version_ 1784892635475869696
author Li, Fanghua
Sun, Anbang
Wu, Feng
Zhang, Dongshan
Zhao, Zhanzheng
author_facet Li, Fanghua
Sun, Anbang
Wu, Feng
Zhang, Dongshan
Zhao, Zhanzheng
author_sort Li, Fanghua
collection PubMed
description OBJECTIVE: Blood pressure (BP) control rates among adult patients taking antihypertensive medications in the United States have not improved over the last decade. Many CKD adults require more than one class of antihypertensive agent to reach the BP target recommended by the guidelines. However, no study has quantified the proportion of adult CKD patients taking antihypertensive medication who are on monotherapy or combination therapy. METHODS: National Health and Nutrition Examination Survey data during 2001-2018 was used, including adults with CKD taking antihypertensive medication (age ≥ 20 years, n = 4,453). BP control rates were investigated under the BP targets recommended by the 2021 KDIGO, the 2012 KDIGO, and the 2017 ACC/AHA guidelines. RESULTS: The percentages of uncontrolled BP among US adults with CKD taking antihypertensive medication were 81.4% in 2001-2006 and 78.2% in 2013-2018. The proportion of monotherapy of antihypertensive regimen were 38.6, 33.3, and 34.6% from 2001 to 2006, 2007-2012, and 2013-2018, with no obvious difference. Similarly, there was no significant change in percentages of dual-therapy, triple-therapy, and quadruple-therapy. Although proportion of CKD adults not treated with ACEi/ARB decreased from 43.5% in 2001-2006 to 32.7% in 2013-2018, treatment of ACEi/ARB among patients with ACR > 300 mg/g had no significant change. CONCLUSION: The BP control rates among US adult CKD patients taking antihypertensive medications have not improved from 2001 to 2018. Mono-therapy accounted for about one third of adult CKD patients taking antihypertensive medication and not changed. Increasing antihypertensive medication combination therapy may help improve BP control in CKD adults in the United States.
format Online
Article
Text
id pubmed-9947777
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99477772023-02-24 Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018 Li, Fanghua Sun, Anbang Wu, Feng Zhang, Dongshan Zhao, Zhanzheng Front Cardiovasc Med Cardiovascular Medicine OBJECTIVE: Blood pressure (BP) control rates among adult patients taking antihypertensive medications in the United States have not improved over the last decade. Many CKD adults require more than one class of antihypertensive agent to reach the BP target recommended by the guidelines. However, no study has quantified the proportion of adult CKD patients taking antihypertensive medication who are on monotherapy or combination therapy. METHODS: National Health and Nutrition Examination Survey data during 2001-2018 was used, including adults with CKD taking antihypertensive medication (age ≥ 20 years, n = 4,453). BP control rates were investigated under the BP targets recommended by the 2021 KDIGO, the 2012 KDIGO, and the 2017 ACC/AHA guidelines. RESULTS: The percentages of uncontrolled BP among US adults with CKD taking antihypertensive medication were 81.4% in 2001-2006 and 78.2% in 2013-2018. The proportion of monotherapy of antihypertensive regimen were 38.6, 33.3, and 34.6% from 2001 to 2006, 2007-2012, and 2013-2018, with no obvious difference. Similarly, there was no significant change in percentages of dual-therapy, triple-therapy, and quadruple-therapy. Although proportion of CKD adults not treated with ACEi/ARB decreased from 43.5% in 2001-2006 to 32.7% in 2013-2018, treatment of ACEi/ARB among patients with ACR > 300 mg/g had no significant change. CONCLUSION: The BP control rates among US adult CKD patients taking antihypertensive medications have not improved from 2001 to 2018. Mono-therapy accounted for about one third of adult CKD patients taking antihypertensive medication and not changed. Increasing antihypertensive medication combination therapy may help improve BP control in CKD adults in the United States. Frontiers Media S.A. 2023-02-09 /pmc/articles/PMC9947777/ /pubmed/36844731 http://dx.doi.org/10.3389/fcvm.2023.990997 Text en Copyright © 2023 Li, Sun, Wu, Zhang and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Li, Fanghua
Sun, Anbang
Wu, Feng
Zhang, Dongshan
Zhao, Zhanzheng
Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018
title Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018
title_full Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018
title_fullStr Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018
title_full_unstemmed Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018
title_short Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018
title_sort trends in using of antihypertensive medication among us ckd adults, nhanes 2001–2018
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947777/
https://www.ncbi.nlm.nih.gov/pubmed/36844731
http://dx.doi.org/10.3389/fcvm.2023.990997
work_keys_str_mv AT lifanghua trendsinusingofantihypertensivemedicationamongusckdadultsnhanes20012018
AT sunanbang trendsinusingofantihypertensivemedicationamongusckdadultsnhanes20012018
AT wufeng trendsinusingofantihypertensivemedicationamongusckdadultsnhanes20012018
AT zhangdongshan trendsinusingofantihypertensivemedicationamongusckdadultsnhanes20012018
AT zhaozhanzheng trendsinusingofantihypertensivemedicationamongusckdadultsnhanes20012018